Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-012755

Oruka Therapeutics, Inc. · ORKA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Feb 16, 2017
Accepted (ET)
Feb 21, 2017 · 4:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000907654

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1holding———767,660IBy Venrock Healthcare Capital Partners II, L.P.
Common StockF2holding———311,272IBy VHCP Co-Investment Holdings II, LLC
Common StockF3holding———390,912IBy Venrock Healthcare Capital Partners, L.P.
Common StockF4holding———71,487IBy VHCP Co-Investment Holdings, LLC

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F5$2.50Feb 16, 2017A10,000A—Feb 15, 2027Common Stock10,00010,000D

Explanation of responses